1. Cell Cycle/DNA Damage Epigenetics Apoptosis
  2. HDAC Apoptosis
  3. HDAC8-IN-15

HDAC8-IN-15 是一种选择性 HDAC8 抑制剂,其 IC50 为 0.40 μM。HDAC8-IN-15 可提高 HDAC8 底物 SMC3 的乙酰化水平,且不会改变 SMC3 的总蛋白水平。HDAC8-IN-15 可降低癌细胞活力、抑制集落形成、减缓细胞迁移、诱导细胞凋亡 (apoptosis),并诱导细胞周期阻滞于 SubG1 期。HDAC8-IN-15 可用于神经母细胞瘤的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

HDAC8-IN-15

HDAC8-IN-15 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

HDAC8-IN-15 is a selective HDAC8 inhibitor with an IC50 of 0.40 μM. HDAC8-IN-15 increases the acetylation level of the HDAC8 substrate SMC3 without altering the total protein level of SMC3. HDAC8-IN-15 reduces cancer cell viability, inhibits colony formation, slows cell migration, induces apoptosis, and causes cell cycle arrest at the SubG1 phase. HDAC8-IN-15 can be used in studies related to neuroblastoma[1].

IC50 & Target[1]

HDAC8

0.4 μM (IC50)

体外研究
(In Vitro)

HDAC8-IN-15 (Compound 9m) 对 IMR32 神经母细胞瘤细胞的增殖抑制作用 (IC50 = 9.92 μM) 比对 HCT-116 结肠癌细胞、MCF7 乳腺癌细胞及正常 HEK293 细胞的抑制作用更强[1]
HDAC8-IN-15 (1-5 μM; 9-12 days) 可强效抑制 IMR32 神经母细胞瘤细胞的集落形成[1]
HDAC8-IN-15 (1-5 μM; 0-48 h) 可抑制 IMR32 神经母细胞瘤细胞的迁移,该作用通过伤口愈合程度降低得到验证[1]
HDAC8-IN-15 (1-5 μM; 48 h) 可剂量依赖性地诱导 IMR32 神经母细胞瘤细胞发生凋亡[1]
HDAC8-IN-15 (1-5 μM; 48 h) 可在 IMR32 神经母细胞瘤细胞中诱导 G1 亚期细胞周期阻滞[1]
HDAC8-IN-15 (1-5 μM; 24 h) 可提高 IMR32 神经母细胞瘤细胞中 SMC3 的乙酰化水平,这与 HDAC8 抑制作用一致[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Migration Assay[1]

Cell Line: IMR32 neuroblastoma cells
Concentration: 1 μM, 5 μM
Incubation Time: 0, 12 and 48 h
Result: Significantly reduced the percentage of wound closure over 48 h compared to untreated controls, indicating inhibited cell migration.

Apoptosis Analysis[1]

Cell Line: IMR32 neuroblastoma cells
Concentration: 1 μM, 5 μM
Incubation Time: 48 h
Result: Induced early apoptosis in ~5% of IMR32 cells and late apoptosis/necrosis in ~2% of cells at 1 μM.
Induced early apoptosis in ~11% of cells and late apoptosis/necrosis in ~5% of cells at 5 μM, compared to minimal apoptosis in untreated controls.

Cell Cycle Analysis[1]

Cell Line: IMR32 neuroblastoma cells
Concentration: 1 μM, 5 μM
Incubation Time: 48 h
Result: Increased the sub-G1 cell population to ~11.2% (from ~2.62% in controls) at 1 μM.
Increased the sub-G1 population to ~20.2% at 5 μM, indicating induction of cell cycle arrest at the sub-G1 phase.

Western Blot Analysis[1]

Cell Line: IMR32 neuroblastoma cells
Concentration: 1 μM, 5 μM
Incubation Time: 24 h
Result: Significantly increased Ac-SMC3 protein levels relative to untreated controls, while total SMC3 and β-actin levels remained unchanged.
分子量

545.89

Formula

C26H27Cl3N6O

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
HDAC8-IN-15
目录号:
HY-181979
需求量: